Amgen's phase 2 data disappointed, but its obesity pipeline still holds potential. See why AMGN stock is appealing even without the full upside from MariTide.
US researchers found levothyroxine, pills that cost just a few pence a day to combat the condition, could raise the risk of the bone-thinning disease osteoporosis.